However, in AD, tau is 3–4 fold more phosphorylated, and it is this hyperphosphorylation that promotes the intraneuronal aggregation of tau into NFTs (Vanmechelen et al., 2000; Parnetti et al., 2001; Buerger et al., 2002). The gene discussed is MAPT; the disease is Alzheimer disease.